Home > Products > CD3 & IGF1R
> Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (Miniantibody)
Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (Miniantibody) (CAT#: MNAB-092)
Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (Miniantibody) is a fusion protein of two scFv fragments combined with distinct specificity. One scFv of an anti-CD3 antibody variable domain is linked to another scFv of an anti-IGF1R antibody variable domain by a flexible hinge region. This BsAb format has the decreased size and better penetration than conventional IgGs in the clinical diagnostics and potentially therapy. This BsAb can retarget T cells to tumor cells. It is designed for the research of Melanoma; Colon cancer; Pancreas cancer; Prostate cancer; Kidney cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (Miniantibody) (MNAB-092). Click the button below to contact us or submit your feedback about this product.